Drug Shortages, APIs Supply and the Pharma Global Value Chain

Tomorrow, start the 13rd European Health Economics Association conference organised in Oslo (NO). I will have the opportunity to make an oral communication in a session on pharmaeconomics, describing the Drug Shortage (DS) and the impact of COVID pandemic, characterising the world distribution of Active Pharmaceutical Ingredients (API) and documenting the pharmaceutical Global Value Chain (GVC) by examining drugs trade balance between countries. You will find the abstract of the communication on the conference website. Thanks to my past pharma graduate students (#BEPIB) who help me to gather some of the data (Quentin Ciepiela, Arthur Lauret, Juliette Zerbib).